Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YI
3151
111 Inc
YI
$33.9M
| $119K | ﹤0.01% |
11,215
-224
| -2% | -$2.53K |
|
3152
Beasley Broadcasting Group
BBGI
$37.8M
| $119K | ﹤0.01% |
9,076
-620
| -6% | -$8.66K |
|
3153
Sono-Tek
SOTK
$81.3M
| $119K | ﹤0.01% |
30,800
+2,400
| +8% | +$10.8K |
|
|
VIRX
3154
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $118K | ﹤0.01% |
217,699
+15,200
| +8% | +$12K |
|
3155
Achieve Life Sciences
ACHV
$659M
| $118K | ﹤0.01% |
25,060
+14,360
| +134% | +$69.2K |
|
3156
Team
TISI
$79.5M
| $118K | ﹤0.01% |
+13,251
| New | +$101K |
|
3157
Generation Income Properties
GIPR
$758K
| $117K | ﹤0.01% |
+2,860
| New | +$116K |
|
3158
Asia Pacific Wire & Cable
APWC
$60.6M
| $116K | ﹤0.01% |
73,200
+200
| +0.3% | +$294 |
|
3159
CPS Technologies
CPSH
$75.5M
| $116K | ﹤0.01% |
68,247
-17,545
| -20% | -$30.9K |
|
3160
Pluri
PLUR
$16.7M
| $116K | ﹤0.01% |
20,025
-14,362
| -42% | -$81K |
|
|
TWOU
3161
DELISTED
2U Inc
TWOU
| $115K | ﹤0.01% |
22,489
-6,584
| -23% | -$57K |
|
3162
Dakota Gold
DC
$608M
| $113K | ﹤0.01% |
44,500
+5,900
| +15% | +$15.7K |
|
|
FNCB
3163
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $113K | ﹤0.01% |
16,800
+500
| +3% | +$2.85K |
|
|
FAT
3164
DELISTED
FAT Brands
FAT
| $113K | ﹤0.01% |
39,468
-28,345
| -42% | -$99.5K |
|
|
PVLA
3165
Palvella Therapeutics
PVLA
$1.99B
| $113K | ﹤0.01% |
11,471
-6,399
| -36% | -$72.2K |
|
|
WHLM
3166
DELISTED
Wilhelmina International, Inc
WHLM
| $111K | ﹤0.01% |
20,400
+500
| +3% | +$2.61K |
|
3167
DarioHealth
DRIO
$70.9M
| $109K | ﹤0.01% |
4,585
-175
| -4% | -$4.96K |
|
3168
Ovid Therapeutics
OVID
$414M
| $109K | ﹤0.01% |
141,200
-15,600
| -10% | -$43.4K |
|
3169
United States Antimony
UAMY
$751M
| $109K | ﹤0.01% |
322,926
+18,928
| +6% | +$5.28K |
|
3170
Urban One Class A
UONE
$22.8M
| $108K | ﹤0.01% |
5,420
-5,720
| -51% | -$124K |
|
|
NBP
3171
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $107K | ﹤0.01% |
63,800
| – | – |
|
|
TLIS
3172
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $107K | ﹤0.01% |
12,299
+2,000
| +19% | +$17.7K |
|
3173
Entera Bio
ENTX
$147M
| $106K | ﹤0.01% |
57,600
-17,300
| -23% | -$37.9K |
|
|
ABX
3174
Abacus Global Management
ABX
$989M
| $106K | ﹤0.01% |
+12,200
| New | +$137K |
|
|
VINC
3175
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $105K | ﹤0.01% |
6,506
+436
| +7% | +$10.9K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.